Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 7, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, August 6, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Salim Syed Maintained (BIIB) at Buy with Decreased Target to $251 on, Aug 6th, 2024
Salim Syed of Mizuho, Maintained "Biogen Inc." (BIIB) at Buy with Decreased Target from $277 to $251 on, Aug 6th, 2024.
Salim has made no other calls on BIIB in the last 4 months.
There are 16 other peers that have a rating on BIIB. Out of the 16 peers that are also analyzing BIIB, 6 agree with Salim's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $210 on, Friday, August 2nd, 2024
- Mohit Bansal of "Wells Fargo" Maintained at Hold with Decreased Target to $225 on, Friday, August 2nd, 2024
- Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $190 on, Friday, August 2nd, 2024
- Colin Bristow of "UBS" Maintained at Hold with Decreased Target to $214 on, Wednesday, April 17th, 2024
- Geoff Meacham of "B of A Securities" Maintained at Hold with Decreased Target to $260 on, Friday, April 12th, 2024
- Chris Schott of "JP Morgan" Maintained at Hold with Decreased Target to $240 on, Thursday, April 11th, 2024
These are the ratings of the 10 analyists that currently disagree with Salim
- Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $285 on, Monday, August 5th, 2024
- Srikripa Devarakonda of "Truist Securities" Reiterated at Strong Buy with Decreased Target to $302 on, Monday, August 5th, 2024
- George Farmer of "Scotiabank" Maintained at Buy with Decreased Target to $244 on, Friday, August 2nd, 2024
- Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $292 on, Friday, August 2nd, 2024
- Brian Skorney of "Baird" Maintained at Buy with Decreased Target to $294 on, Monday, July 29th, 2024
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $313 on, Friday, July 12th, 2024
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $300 on, Thursday, May 23rd, 2024
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy and Held Target at $340 on, Thursday, May 16th, 2024
- Morten Herholdt of "HSBC" Maintained at Strong Buy with Increased Target to $342 on, Friday, May 3rd, 2024
- Jay Olson of "Oppenheimer" Maintained at Buy and Held Target at $270 on, Monday, April 29th, 2024
